Global Recombinant Peptides Market Research Report 2017-2022

Published On: Aug 2017

Format: PDF

Publisher: QY Research

Pages: 102

Report ID: 109057

In this report, the global Recombinant Peptides market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Recombinant Peptides in these regions, from 2012 to 2022 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India
Global Recombinant Peptides market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Sandoz Pharma
Stada Arzneimittel
Amgen
Hospira
Actavis
Cipla Ltd.
Wockhardt Ltd.
Biocon Ltd.
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Glucagon
Calcitonin
Other
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Recombinant Peptides for each application, including
Insulin
Human Growth Hormone
Blood Products
Other

Table of Contents

Global Recombinant Peptides Market Research Report 2017
1 Recombinant Peptides Market Overview
1.1 Product Overview and Scope of Recombinant Peptides
1.2 Recombinant Peptides Segment by Type (Product Category)
1.2.1 Global Recombinant Peptides Production and CAGR (%) Comparison by Type (Product Category) (2012-2022)
1.2.2 Global Recombinant Peptides Production Market Share by Type (Product Category) in 2016
1.2.3 Glucagon
1.2.4 Calcitonin
1.2.5 Other
1.3 Global Recombinant Peptides Segment by Application
1.3.1 Recombinant Peptides Consumption (Sales) Comparison by Application (2012-2022)
1.3.2 Insulin
1.3.3 Human Growth Hormone
1.3.4 Blood Products
1.3.5 Other
1.4 Global Recombinant Peptides Market by Region (2012-2022)
1.4.1 Global Recombinant Peptides Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
1.4.2 North America Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 China Status and Prospect (2012-2022)
1.4.5 Japan Status and Prospect (2012-2022)
1.4.6 Southeast Asia Status and Prospect (2012-2022)
1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Recombinant Peptides (2012-2022)
1.5.1 Global Recombinant Peptides Revenue Status and Outlook (2012-2022)
1.5.2 Global Recombinant Peptides Capacity, Production Status and Outlook (2012-2022)

2 Global Recombinant Peptides Market Competition by Manufacturers
2.1 Global Recombinant Peptides Capacity, Production and Share by Manufacturers (2012-2017)
2.1.1 Global Recombinant Peptides Capacity and Share by Manufacturers (2012-2017)
2.1.2 Global Recombinant Peptides Production and Share by Manufacturers (2012-2017)
2.2 Global Recombinant Peptides Revenue and Share by Manufacturers (2012-2017)
2.3 Global Recombinant Peptides Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Recombinant Peptides Manufacturing Base Distribution, Sales Area and Product Type
2.5 Recombinant Peptides Market Competitive Situation and Trends
2.5.1 Recombinant Peptides Market Concentration Rate
2.5.2 Recombinant Peptides Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Recombinant Peptides Capacity, Production, Revenue (Value) by Region (2012-2017)
3.1 Global Recombinant Peptides Capacity and Market Share by Region (2012-2017)
3.2 Global Recombinant Peptides Production and Market Share by Region (2012-2017)
3.3 Global Recombinant Peptides Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Recombinant Peptides Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Recombinant Peptides Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Recombinant Peptides Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Recombinant Peptides Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Recombinant Peptides Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Recombinant Peptides Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Recombinant Peptides Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Recombinant Peptides Supply (Production), Consumption, Export, Import by Region (2012-2017)
4.1 Global Recombinant Peptides Consumption by Region (2012-2017)
4.2 North America Recombinant Peptides Production, Consumption, Export, Import (2012-2017)
4.3 Europe Recombinant Peptides Production, Consumption, Export, Import (2012-2017)
4.4 China Recombinant Peptides Production, Consumption, Export, Import (2012-2017)
4.5 Japan Recombinant Peptides Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Recombinant Peptides Production, Consumption, Export, Import (2012-2017)
4.7 India Recombinant Peptides Production, Consumption, Export, Import (2012-2017)

5 Global Recombinant Peptides Production, Revenue (Value), Price Trend by Type
5.1 Global Recombinant Peptides Production and Market Share by Type (2012-2017)
5.2 Global Recombinant Peptides Revenue and Market Share by Type (2012-2017)
5.3 Global Recombinant Peptides Price by Type (2012-2017)
5.4 Global Recombinant Peptides Production Growth by Type (2012-2017)

6 Global Recombinant Peptides Market Analysis by Application
6.1 Global Recombinant Peptides Consumption and Market Share by Application (2012-2017)
6.2 Global Recombinant Peptides Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries

7 Global Recombinant Peptides Manufacturers Profiles/Analysis
7.1 Sandoz Pharma
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Recombinant Peptides Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Sandoz Pharma Recombinant Peptides Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.1.4 Main Business/Business Overview
7.2 Stada Arzneimittel
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Recombinant Peptides Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Stada Arzneimittel Recombinant Peptides Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.2.4 Main Business/Business Overview
7.3 Amgen
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Recombinant Peptides Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Amgen Recombinant Peptides Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.3.4 Main Business/Business Overview
7.4 Hospira
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Recombinant Peptides Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Hospira Recombinant Peptides Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.4.4 Main Business/Business Overview
7.5 Actavis
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Recombinant Peptides Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Actavis Recombinant Peptides Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.5.4 Main Business/Business Overview
7.6 Cipla Ltd.
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Recombinant Peptides Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Cipla Ltd. Recombinant Peptides Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.6.4 Main Business/Business Overview
7.7 Wockhardt Ltd.
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Recombinant Peptides Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Wockhardt Ltd. Recombinant Peptides Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.7.4 Main Business/Business Overview
7.8 Biocon Ltd.
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Recombinant Peptides Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Biocon Ltd. Recombinant Peptides Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.8.4 Main Business/Business Overview

8 Recombinant Peptides Manufacturing Cost Analysis
8.1 Recombinant Peptides Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Recombinant Peptides

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Recombinant Peptides Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Recombinant Peptides Major Manufacturers in 2015
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 Global Recombinant Peptides Market Forecast (2017-2022)
12.1 Global Recombinant Peptides Capacity, Production, Revenue Forecast (2017-2022)
12.1.1 Global Recombinant Peptides Capacity, Production and Growth Rate Forecast (2017-2022)
12.1.2 Global Recombinant Peptides Revenue and Growth Rate Forecast (2017-2022)
12.1.3 Global Recombinant Peptides Price and Trend Forecast (2017-2022)
12.2 Global Recombinant Peptides Production, Consumption , Import and Export Forecast by Region (2017-2022)
12.2.1 North America Recombinant Peptides Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.2 Europe Recombinant Peptides Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.3 China Recombinant Peptides Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.4 Japan Recombinant Peptides Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.5 Southeast Asia Recombinant Peptides Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.6 India Recombinant Peptides Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Recombinant Peptides Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Recombinant Peptides Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer